CD36 and stroke disorder: CD91 emerged as a marker associated with greater longitudinal improvement in NIHSS, and CD36 expression in intermediate monocytes revealed a previously unrecognized immune signature linked to recovery in human stroke.<h4>Conclusions</h4>These findings demonstrate that stroke recovery is associated with coordinated, time-dependent reprogramming of circulating monocytes rather than persistent inflammatory activation.